Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

Are you experiencing symptoms of menopause? Have you noticed a change in your mood during your menopausal transition? If you have missed at least two periods, you may be able to take part in a research study. In this study, we want to learn how mood and stress may affect risk for heart disease in women during menopause.

Have you previously been screened for lung cancer? Or are you currently scheduled for a lung cancer screening? We are looking for Black/African American men and women between the ages of 50-80 to participate in a study about lung cancer. Compensation is provided.

The purpose of this immunotherapy study is to compare two different chemotherapy treatments administered before breast cancer surgery to see which has the better outcome.

Do you suffer from migraines? Are you interested in helping with migraine research?

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

Are you a stroke survivor living with arm or hand weakness? Join our research study to help us learn how your brain talks to your muscles. This study involves just one visit with safe, non-invasive brain stimulation and easy movement tasks. Your help could make a big difference in stroke recovery research.

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.